CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −374 | $493.47 | $185K | 797 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −797 | $494.27 | $394K | 0 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −14,625 | 97,125 | ||
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −376 | $480.68 | $181K | 7,499 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −891 | $481.86 | $429K | 6,608 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −471 | $482.72 | $227K | 6,137 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −375 | $483.80 | $181K | 5,762 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −629 | $484.99 | $305K | 5,133 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −899 | $486.05 | $437K | 4,234 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −461 | $487.40 | $225K | 3,773 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −641 | $488.38 | $313K | 3,132 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −364 | $489.49 | $178K | 2,768 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −893 | $490.11 | $438K | 1,875 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −647 | $491.35 | $318K | 1,228 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −598 | $492.44 | $294K | 630 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −201 | $493.47 | $99K | 429 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −429 | $494.27 | $212K | 0 |
| 2026-01-05 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise · Stock Options 10b5-1 | −7,875 | 52,315 | ||
| 2026-01-05 | MALCOLM JAN Director | Sale 10b5-1 | −50 | $495.01 | $25K | 370 |
Page 163 of 171 · 3,408 trades